title: Candida dubliniensis meningitis as delayed sequela of treated C. dubliniensis fungemia.
abstract: We present a case of Candida dubliniensis meningitis that developed 2 months after apparently successful treatment of an episode of C. dubliniensis candidemia in a heart-lung transplant recipient in Australia. This case highlights the importance of follow-up in patients with candidemia or disseminated infection, especially in immunosuppressed patients.
authors.affiliation: St. Vincent's Hospital, Darlinghurst, New South Wales, Australia. vanhal@gotalk.net.au
authors.forename: Sebastian J
authors.initials: SJ
authors.lastname: van Hal
authors.forename: Damien
authors.initials: D
authors.lastname: Stark
authors.forename: John
authors.initials: J
authors.lastname: Harkness
authors.forename: Deborah
authors.initials: D
authors.lastname: Marriott
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use; D002175:Candida / Q000145:classification / Q000302:isolation & purification*; D002177:Candidiasis / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D000077336:Caspofungin; D054714:Echinocandins / Q000627:therapeutic use; D015725:Fluconazole / Q000627:therapeutic use; D016469:Fungemia / Q000150:complications* / Q000188:drug therapy* / Q000382:microbiology; D016027:Heart Transplantation / Q000009:adverse effects; D006801:Humans; D055666:Lipopeptides; D008297:Male; D016921:Meningitis, Fungal / Q000382:microbiology*; D008875:Middle Aged
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D015725:Fluconazole; D000077336:Caspofungin